chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt received FLUZONE HD in left arm AND PNEUMOVAX 23 also in left arm SUNDAY AFTERNOON 8/25/19.  Pt stated she wanted in same arm as her right arm had arthritic pain.  Her huband also got it in same arm but had no reaction.  Monday  8/26/19, she reported she had the "worst flu like-symptoms....whole body aches....worst than arthritic pain."  She took apap extra strength (she is already on norco and celebrex).  Tuesday 8/27/19, she came to the pharmacy counter to share concerns about a rash on her inner arm (shots werer given in deltoid).  She reported her arm to be very sore.  I told her to immediately call her doctor and call me back.  Tuesday 8/27/19, 615pm. Pt called back stating she was on her way to to the hospital.  At the md office, her BP was 190150, she felt SOB and some tighness in her chest.
Onset 10 days post vax, fever 105. CHild never felt ill. Fever treated and abated with Tylenol or Motrin. No firm dx made. Possible benign neutropenia of childhood.
Pt recvd vax 26DEC91 & exp uncontrollable high pitched screaming cry 2 hrs in duration; Seen by MD @ ER 8PM noted leg as red & swollen to knee;
Vomiting beginning 1 day after vaccine. Vomiting has continued periodically for more than 24 hrs. Dr will be giving zofran.
Heavy Dizzy spells/vertigo lasting about 3 hours, starting 3 days after shot, accompanied by ?jelly legs? and heart palpitations.  On and off for 2 weeks.  Visited ER on 5/1 thinking of possible heart attack, all test came back normal. Sent home with not diagnostic ?might be side effects from vaccine?. Still feeling sick not taking second shot
The day the vaccine  was given a small hematoma formed at the injection site.  Patient was instructed to apply ice to site once she got home and to take Tylenol.  On 4-21-2020 patient was still having pain and visited her primary care physician.  Her physician prescribed Gabapentin 100 mg once a day
Patient developed hard, swollen area around injection site 1 week after injection.  Area was very hot to the touch.
Development of Asymptomatic cardiac arrhythmias including 7% PCV's, isolated runs of Ventricular tachycardia and supraventricular tachycardia
Monday, 1/11/2021 (8:30a):        2nd dose administered ? I felt fine the rest of the day and when going to bed. Overnight, I started to experience chills followed by extreme perspiration and weakness to the point that I struggled to open a bottle of water I had by my bed.  Tuesday, 1/12/2021:                       Headache, weak and tired but attempted to work.  I had to leave shortly after arriving because my symptoms were becoming progressively worse to the point I almost passed out from standing.  Upon arriving home, I started to experience nausea and vomiting x 3. Intense chills followed by the extreme perspiration still existed.  Most of these symptoms subsided by 9:30p that evening.  Wednesday, 1/13/2021:                Intense headache, weakness and dizziness.  Of note, my left underarm/armpit (the arm where the vaccine was administered) is sensitive to touch.
This vaccine is administered in two injections. The first was on 02/06/19 and the second on 04/09/19. A few days after the first injection, I had back and leg pain. After the second shot I could barely get out of bed. My hands, arms and shoulders were so sore I was unable to dress my self for several weeks. I contacted Dr. and he said the Shingrex was not a factor.  A few weeks later I went to a Rheumatoligst and was diagnosed with rheumatoid arthritis. I am currently taking methotrexate that has somewhat helped, but my shoulders remain very sore. I am unable to any lifting.
POST VACCINE, PATIENT LOST CONSCIOUSNESS FOR ABOUT 30 SECONDS PER SIG OTHER. ASSISTED TO FLOOR, PLACED ON STRETCHER IN TRENDELENBERG AND TAKEN TO OBS AT 1315. PATIENT STATES S/S RESOLVED ONCE ARRIVING TO OBS. VSS AND MAINTAINED UNTIL STANDING POSITION. PER ON SITE MD, PT EXPERIENCED CLASSIC SYNCOPAL VASOVAGAL REACTION- RESOLVED. PATIENT RELEASED WITH NO ISSUES AT 1330.  1320 INITIAL BP 154/89 HR 74 SATS 97% RA 1325 SITTING BP 150/78 HR 80 SATS 98% RA 1330 STANDING BP 139/87 HR 80 SATS 99% RA
got shots early this AM 930AM @ clinic-started crying & screaming off & on-leg got red & rashed up
Local skin reaction 8 X 5 1/2 cm errythema. Slightly warm to touch. No induration and no streaking.  Treated with cool compresses and monitoring. No medication prescribed.
Patient reported right shoulder, pectoral muscle and arm pit swelling overnight with visible signs upon waking.  Tender to the touch at point of swelling (not at injection site). Patient reported to the pharmacy Monday morning and said it was improved, still a little sore but swelling was down.  No fever or other symptoms to report - not even sure it was from the shot but the timing coincided within 12 hours of administration and patient did not knowingly experience any other events that would have precipitated the reaction.
w/in 7hr p/vax pt exhibited gen covering of hives over entire skin surface;parents did not take pt to MD but administered DPH;hives lasted 3 days w/fever;
38 y/o male, presented today with a reaction to his 3rd anthrax vaccination.  He has been in-country for about 4 months.  This was his third dose, other doses were 9/2011, 1/2012 and then again 48 hours ago. No previous complaints following any previous vaccinations. I saw him initially this morning about 48 hours after his vaccination. He works the night shift and came in directly after his shift.  He developed an erythematous, edematous, indurated reaction.  It has continued to worsen over the last 24 hours.  His right upper arm measured around his upper bicep is about 2 CM larger compared to the contralateral arm.  The erythema is not circumferential, only about 60% of his arm upper arm is involved. On the lateral aspect of his arm there is a large area of firm induration measuring about the size of his palm.  He is relatively non-tender.  He feels mild discomfort from the tightness/edema. I marked it, gave him 15mg of Mobic and asked him to return after he sleeps or sooner if he worsens. I just saw him again today 12 hours later.  The only change is a slightly larger area of erythema.  No additional tenderness.  He has no functional complaints. Distal neurovascular exam is WNL.  Measurements include the erythematous area of 18 proximal to distal x 20cm (total bicep circumference is 32cm). The area of induration is 9cm x 9cm.
Freezing, pain in mouth, ears, neck, hands, back, knees, basically all over. Fever. When I first checked it was 101.2. I took 2 ibuprofen every 4 hours. Around 9pm the fever broke and chills stopped. The next day, as time went on, I felt better and better until about 48 hours post vaccine I again felt normal.
Patient recieved Proquad ( MMR+Varicella) and was supposed to recieve MMR
Information has been received from a pharmacist referring to multiple patients of unknown age and gender. The patients' pertinent medical history, drug reactions/allergies and concomitant medication were not provided. On unknown dates, the patients were vaccinated with improperly stored VARIVAX (lot # K018963, expiration date 15-OCT-2016; dose and route were unknown). No adverse effects were reported. The temperature excursion included 30 minutes at -11.6 Celsius degree, 2 hours and 30 minutes at -8.7 Celsius degree, 1 hour and 30 minutes at -9.2 Celsius degree, 1 hour and 15 minutes at -9.8 Celsius degree. Data logger was involved. There was no previous temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested.
Nausea, generalized weakness, body aches, fever/chills, mumbling and babbling, rapid speech. She felt like she was having a stroke. Started when she woke up the morning after the vaccine was given.
Pt recvd Hep B vax w/ a higher dose than was recommended & devel alkalosis; It was felt that pt's exp was life-threatening; no further details were provided;
Within 1-2 minutes of receiving 1st Moderna vaccine, client lost consciousness, exhibited seizure activity. Regained consciousness with-in 1-2 minutes.  Client assisted to wheelchair, transported to EMS observation area. Extended observation x 15-20 minutes. Client reported "feeling fine", declined transport to ED. Client left in stable condition under own power.
Extreme chest pain, light headed, pale, some nausea, fatigue, very high blood pressure, heart palpitations.  *went to emergency room via ambulance. His blood pressure was 190/90 at first in the ambulance before starting to go down. Slight symptoms began in the morning but escalated around 2:45pm. We headed out to get him checked just before 3pm but had to call Paramedics while still in the neighborhood as he was having more extreme chest pain and became very pale. Left ER after 6pm. At the hospital he was given an NSAID and  SALINE via I.V. He also had a chest X-ray. We were told to give him ibuprofen for one week. The doctor said he had likely inflammation of cartilage & muscle in his chest wall which had caused the pain. It has now been 4 days since this occurred and he has only complained of slight chest pain on occasion.
Hospitalization: Admitted 8/25/22, discharged 9/4/22.  Presentation to the ED: generalized weakness, nausea, vomiting and diarrhea, initial encounter afebrile and hemodynamically stable, examination notable for dehydration, basic labs showing severe hyponatremia 115, hypokalemia 3.1, AKI, hypomagnesemia and urinalysis suggestive of UTI. COVID-19 + date: 8/19/22 Treatment: Paxlovid.  Discharge to: Hospice.
Soreness in left arm; This is a spontaneous report from a contactable consumer (patient herself). A 42-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number and expiry date not reported) via an unspecified route of administration in Arm Left on 06Mar2021 at 13:30 as 1st dose, single dose for COVID-19 immunisation. The patient was pregnant. The patient's medical history was none. There were no known allergies. The patient's concomitant medication(s) included montelukast taken for an unspecified indication, azelastine taken for an unspecified indication, ethinylestradiol, norgestimate (ESTARYLLA) taken for an unspecified indication and Doterra Oils' taken for unspecified indication. No other vaccine in four weeks. No COVID prior vaccination and not tested COVID post vaccination. On 06Mar2021 at 19:00, the patient experienced soreness in left arm. Therapeutic measures were not taken as a result of adverse event. It was reported that lot was not reported as unable to locate or read the details. The outcome of the event was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Had Flu-like symptoms, runny nose, sore throat, coughing (persistant) major congestion Took mucinex and bush tea (lemon grass, basum, cattle tongue, morenga, bay leaves) and emergen-c  in water. as of 14 nov 2020 Runny nose and congestion have disappeared but the cough, though less, has remained. (dry cough)
Two Dtap-Hep B-Polio (Pediarix) were given at the same time.
Approximately 20 minutes after the vaccine was administered, the patient began wheezing with shortness of breath, used inhaler but needed medical attention.  Epi-pen was administered along with IM Benadryl and then patient was taken to Hospital by ambulance.
dose 1: fever chills headache for about 3 days , tylenol taken  dose 2: no fever, no tylenol taken, chills the first night, pain and swelling in neck and spine only at night for 2 nights , very slight headache, slight fatigue and nausea and weakness after naps, then fine by day 3 then suddenly this morning I had slight chest pain (pressure) and severe vertigo and fell in the bathroom, bp normal, temperature normal, spo2 nornal, normal hr, i had no choice but to report to work or i would lose my job (teaching in private school)
11:00 t103.7;took nap @ babysitters which is very unusual;c/o sore arm, some nausea;saw PCP following day & was doing well;
Gave vaccines on Thursday, 2 1/2 days later, Saturday began breaking out w/vesicular lesions on abdomen. Fever of 101-102 for 2-3 days w increasing outbreak of lesions up to >200 over entire body (+) pruritis. On day 5 ousted lesions no fever, eating and drinking and playing well.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Feb2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 14Mar2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 25Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 32 years, in left arm for Covid-19 immunisation; CoviD-19 vaccine miRNA (miRNA 1273) (MODERNA COVID-19 VACCINE), on 26Jan2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for Covid-19 immunisation. The patient's relevant medical history included: "Hypocomplementemia urticarial vasculitis treated with Rituximab" (unspecified if ongoing), notes: Hypocomplementemia urticarial vasculitis treated with Rituximab. There were no concomitant medications. Past drug history included: Rituximab, reaction(s): "Allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "testing positive for COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, Covid-19. Clinical course: Patient received no other medication in 2 weeks. After testing positive for COVID 19, I began taking Paxlovid. I almost immediately began to get better, and at the conclusion of the Paxlovid was symptom free and testing negative on rapid antigen test. Originally I was symptomatic mostly in my throat. Approximately 4 days after I finished the Paxlovid, I began to be moderately Ill, with symptoms mostly in my sinuses and lungs. I began testing positive again on rapid antigen and had a temp max 102.6 F. I tested positive on rapid antigen test on day 9 after initial illness, 4 days after testing negative. I was symptomatic and ill for approximately 5 days, and continued testing positive on rapid antigen until day 20 from initial symptom onset. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Approx. 1/10/21 --R arm, red little knot itching few days after then resolved. 1/19/21 R arm, large red very itchy area, deeper red area in injection site, very warm touch.
Vertigo,  Vomiting,  Dizziness,  face numbness, double vision,  left arm is difficult to use, went to the emergency,  given Meclizine, baby aspirin,  Atorvastatin Calcium  I still have difficulty walking,  double vision comes and goes my balance is still off
onset symptoms 9/6/21. Several Emergency dept visits on 9/6, 9/8, 9/15, 9/22 and admitted 9/25 Hospitalized
Vac. #1: Fever, fatigue, joint aches, nausea, painful left arm beginning 12 hours post injection lasting 36 hours .  These symptoms were significant .  Vac. #2: Fever, fatigue, joint aches and minimal nausea with painful left arm lasting 24 hours.  These symptom were not as significant as the first but very close to the same.  One week post second injection I developed a Herpes lesson on my lower  lip (right side) which I have not had since early childhood.  This lesson was very sizable and lasted 2 weeks. This lesson also involved my trigeminal nerve as I had pain over the entire nerve length from my lip up into my scalp.
Severe body aches head to toe. Headache chills joints ankles hurt all over very fatigue
I felt extremely fatigued and light headed or faint.  It was enough that I called in sick to work the next day and went to bed 3 hours ahead of my normal bedtime.  The onset may have been earlier in the day, but I assumed it was fatigue or not having had my coffee yet. I had a similar fatigued, somewhat dizzy or light headed ailment a few months previous and both times have been about 1.5-2 weeks after the HPV vaccine was administered.   Given the time gap it may be conincidental, but it does seem similar.
3/28/04 Localized reaction, site red, swollen, warm 4pm to touch. Instructed mom on Motrin, Ice, return to clinic if worsens.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 04-DEC-2010, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On an unknown date in 2011, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
headaches; dehydration; nausea; vomiting; diarrhea; This is a spontaneous report from a contactable healthcare professional, the patient. A 33-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EJ1685) solution for injection in the right arm on 22Dec2020 at 15:45 (at the age of 33-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history was unknown. Concomitant medications included amoxicillin, diphenhydramine hydrochloride (BENADRYL) and birth control. Past drug history included known allergies: cyclobenzaprine. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 23Dec2020 at 08:15, the patient experienced headaches, dehydration, nausea, vomiting and diarrhea. No treatment was provided for the events headaches, dehydration, nausea, vomiting and diarrhea. The outcome of the events headaches, dehydration, nausea, vomiting and diarrhea was unknown. Since the vaccination, the patient has not been tested for COVID-19.
(LE) weakness, rt leg needs AFO, lt leg sl numb, rt leg dec mobility, lt hand tingling, rt arm tingling, rt hand dec mobility, numbness abd (mid);
This case was reported by a physician via call center representative and described the occurrence of adverse reaction in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to SHINGRIX. Additional details were provided as follows: This case was reported via chat. The age at the vaccination was not reported. The age group was not reported, but was captured as adult as per the vaccine indication. The reporter had a question regarding SHINGRIX vaccine reaction (unspecified) and pre medication recommendations for the 2nd dose to prevent the similar reaction. The reporter did not consent to follow-up. No further details were provided. The healthcare professional abandoned the chat.
Pt had 1st moderna shot in 5/2021 - no second shot received.  Now admitted to hospital with COVID 9/10/2021
1) Swelling at site of Prevnar vaccine 24 hours after receiving vaccine.  4 x 3 cm red/indurated area right thigh.  2) Eczema worse.  Right popliteal area with oozing dry patch.
Information has been received from a physician concerning a 14 year old female patient who on 15-JUL-1997 was vaccinated with the first dose of MMR II. On 06-DEC-1999 the patient was vaccinated with the second dose of MMR II. There was no lot number reported. On 16-NOV-2009 the patient experienced mumps, patient was diagnosed on 03-JAN-2010. The patient was afebile and experienced parotitis on the left side. The outcome of the patient was not reported. Follow-up information was received which reported that the 14 year old (also reported as 13 year old) patient experienced mumps on 27-NOV-2009 (previously reported on 16-NOV-2009). The patient was diagnosed on 29-NOV-2009. The patient had a fever of 101.5 degree F and right side parotitis. This is one of several reports from the same source. No further information is available.
Patient had a vagal response to injection & lost consciousness for approx. 60 seconds while seated in a chair. He was dyphoretic and pale. VS were obtained, wnl. BP 98/66, HR 63, RR 16, O2 98%. Patient stated this BP was normal for him. He stated he has a history of vagal response to injections, but didn't tell his vaccinator prior to administration b/c it hadn't happened recently. He also stated he is Type 1 Diabetic. His blood sugar was 110 per his personal continuous monitor. He stated he had been for a long run that morning & had eaten on his way to the clinic site. He was transferred to a stretcher and remained in observation for 45 minutes.
PT COMPLAINED OF SHORTNESS OF BREATH, TURNED WHITE, WAS DIZZY AND ABOUT TO PASS OUT.
Drug Allergies: Prevnar-13- Cellulitis/Allergies: Prevnar-13; Drug Allergies: Prevnar-13- Cellulitis/Allergies: Prevnar-13; This is a spontaneous report from a Pfizer-sponsored program. A contactable Physician reported that a 72-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced drug allergies and cellulitis on an unspecified date with outcome of unknown.; Sender's Comments: Based on the information currently available, a contributory role of PREVNAR 13 towards the occurrence of events drug allergies and cellulitis cannot be fully excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Diagnosis of Bells Palsy on 14Apr2021; This is a spontaneous report from a contactable consumer.   A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), dose 1 via an unspecified route of administration, administered in the left arm  on 26Mar2021, at 11:00 as single dose for covid-19 immunization.  Medical history included hypertension from an unknown date . No known allergies were noted.  There were no concomitant medications.  The patient had diagnosis of Bells palsy on 14apr2021 on 14Apr2021, at 06:00. The event resulted in Emergency room/department or urgent care visit. Prior to vaccination, the patient  had not been diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were taken as a result of diagnosis of bells palsy on 14apr2021, and included treatment with predisone (x 5 days) and anti-viral (x 10 days). The outcome of diagnosis of Bells palsy on 14apr2021 was not recovered.